Inherited metabolic diseases coverage by health plans requirement provision
Minnesota bill mandates health insurance coverage for inherited metabolic disease screening, diagnosis, and treatment to ensure access for rare genetic condition patients.
Minnesota bill mandates health insurance coverage for inherited metabolic disease screening, diagnosis, and treatment to ensure access for rare genetic condition patients.
SF 1023 requires health insurance plans in Minnesota to provide coverage for screening, diagnosis, and treatment of inherited metabolic diseases. The bill establishes mandated benefits that insurers must include in their health plans, ensuring patients with these rare genetic conditions have access to necessary medical interventions without coverage denial.
Inherited metabolic diseases are rare but serious genetic conditions that can cause severe disability or death if left untreated. Many affected families face significant out-of-pocket costs or coverage denials, making early detection and treatment inaccessible. This mandate would standardize coverage across plans, improving outcomes for patients with conditions like phenylketonuria (PKU), maple syrup urine disease, and other metabolic disorders.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.